Pineal Region Gliomas: A Systematic Review of Clinical Features and Treatment Outcomes
dc.contributor.author | Bin Alamer, Othman | |
dc.contributor.author | Palmisciano, Paolo | |
dc.contributor.author | Rowe, Scott E. | |
dc.contributor.author | Gupta, Aditya Dutta | |
dc.contributor.author | Haider, Maryam | |
dc.contributor.author | Alduhaymi, Mohammed | |
dc.contributor.author | Cohen-Gadol, Aaron A. | |
dc.contributor.author | Yu, Kenny | |
dc.contributor.author | El-Ahmadieh, Tarek Y. | |
dc.contributor.author | Haider, Ali S. | |
dc.contributor.department | Neurological Surgery, School of Medicine | |
dc.date.accessioned | 2023-10-26T14:26:39Z | |
dc.date.available | 2023-10-26T14:26:39Z | |
dc.date.issued | 2022 | |
dc.description.abstract | Background/aim: To review the current literature on pineal region gliomas, summarizing the clinical characteristics and treatment outcomes. Materials and methods: PubMed, Scopus, and Cochrane databases were used to identify relevant articles. Comprehensive clinical characteristic review and survival analysis were conducted. Results: Twelve studies describing 81 patients were included. The median age was 39 years (male=54.3%). Fifty patients (61.7%) had obstructive hydrocephalus requiring cerebrospinal fluid diversion with either ventriculoperitoneal shunt (VPS) (40.0%) or endoscopic third ventriculostomy (ETV) (24.0%). Patients who underwent VPS had significant survival benefits compared to ETV (p<0.05). All patients in our review underwent surgery, and gross-total resection (≥98%) was achieved in 34.6%. The supracerebellar infratentorial approach was the most employed surgical approach (62.3%). Chemotherapy was administered in 32.1% of cases, and radiotherapy in 40.7%. The median overall survival (OS) was 12 months, and the overall one-year survival rate was 60%. Conclusion: This study could not establish a correlation between the extent of tumor resection and positive treatment outcomes. However, among cases with hydrocephalus, patients who underwent VPS placement had better survival as compared to ETV. | |
dc.eprint.version | Author's manuscript | |
dc.identifier.citation | Bin Alamer O, Palmisciano P, Rowe SE, et al. Pineal Region Gliomas: A Systematic Review of Clinical Features and Treatment Outcomes. Anticancer Res. 2022;42(3):1189-1198. doi:10.21873/anticanres.15585 | |
dc.identifier.uri | https://hdl.handle.net/1805/36700 | |
dc.language.iso | en_US | |
dc.publisher | International Institute of Anticancer Research | |
dc.relation.isversionof | 10.21873/anticanres.15585 | |
dc.relation.journal | Anticancer Research | |
dc.rights | Publisher Policy | |
dc.source | PMC | |
dc.subject | Pineal region glioma | |
dc.subject | Glioma | |
dc.subject | Pineal region tumors | |
dc.subject | Systematic review | |
dc.title | Pineal Region Gliomas: A Systematic Review of Clinical Features and Treatment Outcomes | |
dc.type | Article |